Compile Data Set for Download or QSAR
Report error Found 86 Enz. Inhib. hit(s) with all data for entry = 11426
TargetCannabinoid receptor 2(Human)
Individual

US Patent
LigandPNGBDBM614237(US11746113, Compound 4.7)
Affinity DataKi: <10nMAssay Description:The ability of some of the ligands to bind to the CB1/CB2 receptors with a tight/irreversible binding mode was determined by measuring reductions in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
Go to US Patent

TargetCannabinoid receptor 2(Human)
Individual

US Patent
LigandPNGBDBM614232(US11746113, Compound 3.14)
Affinity DataKi: <10nMAssay Description:The ability of some of the ligands to bind to the CB1/CB2 receptors with a tight/irreversible binding mode was determined by measuring reductions in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
Go to US Patent

TargetCannabinoid receptor 1(Human)
Individual

US Patent
LigandPNGBDBM614233(US11746113, Compound 3.16)
Affinity DataKi: <10nMAssay Description:The ability of some of the ligands to bind to the CB1/CB2 receptors with a tight/irreversible binding mode was determined by measuring reductions in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
Go to US Patent

TargetCannabinoid receptor 2(Human)
Individual

US Patent
LigandPNGBDBM614233(US11746113, Compound 3.16)
Affinity DataKi: <10nMAssay Description:The ability of some of the ligands to bind to the CB1/CB2 receptors with a tight/irreversible binding mode was determined by measuring reductions in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
Go to US Patent

TargetCannabinoid receptor 1(Human)
Individual

US Patent
LigandPNGBDBM614263(US11746113, Compound 10.13)
Affinity DataKi: <10nMAssay Description:The ability of some of the ligands to bind to the CB1/CB2 receptors with a tight/irreversible binding mode was determined by measuring reductions in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
Go to US Patent

TargetCannabinoid receptor 1(Human)
Individual

US Patent
LigandPNGBDBM614235(US11746113, Compound 4.2)
Affinity DataKi: <10nMAssay Description:The ability of some of the ligands to bind to the CB1/CB2 receptors with a tight/irreversible binding mode was determined by measuring reductions in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
Go to US Patent

TargetCannabinoid receptor 2(Human)
Individual

US Patent
LigandPNGBDBM614235(US11746113, Compound 4.2)
Affinity DataKi: <10nMAssay Description:The ability of some of the ligands to bind to the CB1/CB2 receptors with a tight/irreversible binding mode was determined by measuring reductions in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
Go to US Patent

TargetCannabinoid receptor 1(Human)
Individual

US Patent
LigandPNGBDBM614236(US11746113, Compound 4.4)
Affinity DataKi: <10nMAssay Description:The ability of some of the ligands to bind to the CB1/CB2 receptors with a tight/irreversible binding mode was determined by measuring reductions in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
Go to US Patent

TargetCannabinoid receptor 2(Human)
Individual

US Patent
LigandPNGBDBM614236(US11746113, Compound 4.4)
Affinity DataKi: <10nMAssay Description:The ability of some of the ligands to bind to the CB1/CB2 receptors with a tight/irreversible binding mode was determined by measuring reductions in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
Go to US Patent

TargetCannabinoid receptor 1(Human)
Individual

US Patent
LigandPNGBDBM614237(US11746113, Compound 4.7)
Affinity DataKi: <10nMAssay Description:The ability of some of the ligands to bind to the CB1/CB2 receptors with a tight/irreversible binding mode was determined by measuring reductions in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
Go to US Patent

TargetCannabinoid receptor 2(Human)
Individual

US Patent
LigandPNGBDBM614222(US11746113, Compound 3.1)
Affinity DataKi: <10nMAssay Description:The ability of some of the ligands to bind to the CB1/CB2 receptors with a tight/irreversible binding mode was determined by measuring reductions in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
Go to US Patent

TargetCannabinoid receptor 1(Human)
Individual

US Patent
LigandPNGBDBM614262(US11746113, Compound 10.12)
Affinity DataKi: <10nMAssay Description:The ability of some of the ligands to bind to the CB1/CB2 receptors with a tight/irreversible binding mode was determined by measuring reductions in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
Go to US Patent

TargetCannabinoid receptor 1(Human)
Individual

US Patent
LigandPNGBDBM614240(US11746113, Compound 5.10)
Affinity DataKi: <10nMAssay Description:The ability of some of the ligands to bind to the CB1/CB2 receptors with a tight/irreversible binding mode was determined by measuring reductions in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
Go to US Patent

TargetCannabinoid receptor 2(Human)
Individual

US Patent
LigandPNGBDBM614240(US11746113, Compound 5.10)
Affinity DataKi: <10nMAssay Description:The ability of some of the ligands to bind to the CB1/CB2 receptors with a tight/irreversible binding mode was determined by measuring reductions in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
Go to US Patent

TargetCannabinoid receptor 1(Human)
Individual

US Patent
LigandPNGBDBM614256(US11746113, Compound 10.6)
Affinity DataKi: <10nMAssay Description:The ability of some of the ligands to bind to the CB1/CB2 receptors with a tight/irreversible binding mode was determined by measuring reductions in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
Go to US Patent

TargetCannabinoid receptor 1(Human)
Individual

US Patent
LigandPNGBDBM614255(US11746113, Compound 10.5)
Affinity DataKi: <10nMAssay Description:The ability of some of the ligands to bind to the CB1/CB2 receptors with a tight/irreversible binding mode was determined by measuring reductions in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
Go to US Patent

TargetCannabinoid receptor 1(Human)
Individual

US Patent
LigandPNGBDBM614222(US11746113, Compound 3.1)
Affinity DataKi: <10nMAssay Description:The ability of some of the ligands to bind to the CB1/CB2 receptors with a tight/irreversible binding mode was determined by measuring reductions in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
Go to US Patent

TargetCannabinoid receptor 1(Human)
Individual

US Patent
LigandPNGBDBM614254(US11746113, Compound 10.4)
Affinity DataKi: <10nMAssay Description:The ability of some of the ligands to bind to the CB1/CB2 receptors with a tight/irreversible binding mode was determined by measuring reductions in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
Go to US Patent

TargetCannabinoid receptor 1(Human)
Individual

US Patent
LigandPNGBDBM614252(US11746113, Compound 10.2)
Affinity DataKi: <10nMAssay Description:The ability of some of the ligands to bind to the CB1/CB2 receptors with a tight/irreversible binding mode was determined by measuring reductions in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
Go to US Patent

TargetCannabinoid receptor 2(Human)
Individual

US Patent
LigandPNGBDBM614251(US11746113, Compound 10.1)
Affinity DataKi: <10nMAssay Description:The ability of some of the ligands to bind to the CB1/CB2 receptors with a tight/irreversible binding mode was determined by measuring reductions in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
Go to US Patent

TargetCannabinoid receptor 2(Human)
Individual

US Patent
LigandPNGBDBM614226(US11746113, Compound 3.8)
Affinity DataKi: <10nMAssay Description:The ability of some of the ligands to bind to the CB1/CB2 receptors with a tight/irreversible binding mode was determined by measuring reductions in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
Go to US Patent

TargetCannabinoid receptor 1(Human)
Individual

US Patent
LigandPNGBDBM614224(US11746113, Compound 3.3)
Affinity DataKi: <10nMAssay Description:The ability of some of the ligands to bind to the CB1/CB2 receptors with a tight/irreversible binding mode was determined by measuring reductions in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
Go to US Patent

TargetCannabinoid receptor 2(Human)
Individual

US Patent
LigandPNGBDBM614224(US11746113, Compound 3.3)
Affinity DataKi: <10nMAssay Description:The ability of some of the ligands to bind to the CB1/CB2 receptors with a tight/irreversible binding mode was determined by measuring reductions in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
Go to US Patent

TargetCannabinoid receptor 1(Human)
Individual

US Patent
LigandPNGBDBM614225(US11746113, Compound 3.4)
Affinity DataKi: <10nMAssay Description:The ability of some of the ligands to bind to the CB1/CB2 receptors with a tight/irreversible binding mode was determined by measuring reductions in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
Go to US Patent

TargetCannabinoid receptor 2(Human)
Individual

US Patent
LigandPNGBDBM614223(US11746113, Compound 3.2)
Affinity DataKi: <10nMAssay Description:The ability of some of the ligands to bind to the CB1/CB2 receptors with a tight/irreversible binding mode was determined by measuring reductions in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
Go to US Patent

TargetCannabinoid receptor 2(Human)
Individual

US Patent
LigandPNGBDBM614225(US11746113, Compound 3.4)
Affinity DataKi: <10nMAssay Description:The ability of some of the ligands to bind to the CB1/CB2 receptors with a tight/irreversible binding mode was determined by measuring reductions in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
Go to US Patent

TargetCannabinoid receptor 1(Human)
Individual

US Patent
LigandPNGBDBM614226(US11746113, Compound 3.8)
Affinity DataKi: <10nMAssay Description:The ability of some of the ligands to bind to the CB1/CB2 receptors with a tight/irreversible binding mode was determined by measuring reductions in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
Go to US Patent

TargetCannabinoid receptor 1(Human)
Individual

US Patent
LigandPNGBDBM614223(US11746113, Compound 3.2)
Affinity DataKi: <10nMAssay Description:The ability of some of the ligands to bind to the CB1/CB2 receptors with a tight/irreversible binding mode was determined by measuring reductions in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
Go to US Patent

TargetCannabinoid receptor 1(Human)
Individual

US Patent
LigandPNGBDBM614227(US11746113, Compound 3.9)
Affinity DataKi: <10nMAssay Description:The ability of some of the ligands to bind to the CB1/CB2 receptors with a tight/irreversible binding mode was determined by measuring reductions in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
Go to US Patent

TargetCannabinoid receptor 2(Human)
Individual

US Patent
LigandPNGBDBM614227(US11746113, Compound 3.9)
Affinity DataKi: <10nMAssay Description:The ability of some of the ligands to bind to the CB1/CB2 receptors with a tight/irreversible binding mode was determined by measuring reductions in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
Go to US Patent

TargetCannabinoid receptor 1(Human)
Individual

US Patent
LigandPNGBDBM614228(US11746113, Compound 3.10)
Affinity DataKi: <10nMAssay Description:The ability of some of the ligands to bind to the CB1/CB2 receptors with a tight/irreversible binding mode was determined by measuring reductions in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
Go to US Patent

TargetCannabinoid receptor 2(Human)
Individual

US Patent
LigandPNGBDBM614228(US11746113, Compound 3.10)
Affinity DataKi: <10nMAssay Description:The ability of some of the ligands to bind to the CB1/CB2 receptors with a tight/irreversible binding mode was determined by measuring reductions in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
Go to US Patent

TargetCannabinoid receptor 1(Human)
Individual

US Patent
LigandPNGBDBM614229(US11746113, Compound 3.11)
Affinity DataKi: <10nMAssay Description:The ability of some of the ligands to bind to the CB1/CB2 receptors with a tight/irreversible binding mode was determined by measuring reductions in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
Go to US Patent

TargetCannabinoid receptor 2(Human)
Individual

US Patent
LigandPNGBDBM614229(US11746113, Compound 3.11)
Affinity DataKi: <10nMAssay Description:The ability of some of the ligands to bind to the CB1/CB2 receptors with a tight/irreversible binding mode was determined by measuring reductions in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
Go to US Patent

TargetCannabinoid receptor 1(Human)
Individual

US Patent
LigandPNGBDBM614230(US11746113, Compound 3.12)
Affinity DataKi: <10nMAssay Description:The ability of some of the ligands to bind to the CB1/CB2 receptors with a tight/irreversible binding mode was determined by measuring reductions in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
Go to US Patent

TargetCannabinoid receptor 2(Human)
Individual

US Patent
LigandPNGBDBM614230(US11746113, Compound 3.12)
Affinity DataKi: <10nMAssay Description:The ability of some of the ligands to bind to the CB1/CB2 receptors with a tight/irreversible binding mode was determined by measuring reductions in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
Go to US Patent

TargetCannabinoid receptor 1(Human)
Individual

US Patent
LigandPNGBDBM614231(US11746113, Compound 3.13)
Affinity DataKi: <10nMAssay Description:The ability of some of the ligands to bind to the CB1/CB2 receptors with a tight/irreversible binding mode was determined by measuring reductions in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
Go to US Patent

TargetCannabinoid receptor 1(Human)
Individual

US Patent
LigandPNGBDBM614232(US11746113, Compound 3.14)
Affinity DataKi: <10nMAssay Description:The ability of some of the ligands to bind to the CB1/CB2 receptors with a tight/irreversible binding mode was determined by measuring reductions in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
Go to US Patent

TargetCannabinoid receptor 2(Human)
Individual

US Patent
LigandPNGBDBM614248(US11746113, Compound 9.14)
Affinity DataKi:  105nMAssay Description:The ability of some of the ligands to bind to the CB1/CB2 receptors with a tight/irreversible binding mode was determined by measuring reductions in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
Go to US Patent

TargetCannabinoid receptor 2(Human)
Individual

US Patent
LigandPNGBDBM614243(US11746113, Compound 9.9)
Affinity DataKi:  105nMAssay Description:The ability of some of the ligands to bind to the CB1/CB2 receptors with a tight/irreversible binding mode was determined by measuring reductions in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
Go to US Patent

TargetCannabinoid receptor 2(Human)
Individual

US Patent
LigandPNGBDBM614252(US11746113, Compound 10.2)
Affinity DataKi:  105nMAssay Description:The ability of some of the ligands to bind to the CB1/CB2 receptors with a tight/irreversible binding mode was determined by measuring reductions in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
Go to US Patent

TargetCannabinoid receptor 1(Human)
Individual

US Patent
LigandPNGBDBM614251(US11746113, Compound 10.1)
Affinity DataKi:  105nMAssay Description:The ability of some of the ligands to bind to the CB1/CB2 receptors with a tight/irreversible binding mode was determined by measuring reductions in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
Go to US Patent

TargetCannabinoid receptor 1(Human)
Individual

US Patent
LigandPNGBDBM614253(US11746113, Compound 10.3)
Affinity DataKi:  105nMAssay Description:The ability of some of the ligands to bind to the CB1/CB2 receptors with a tight/irreversible binding mode was determined by measuring reductions in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
Go to US Patent

TargetCannabinoid receptor 2(Human)
Individual

US Patent
LigandPNGBDBM614254(US11746113, Compound 10.4)
Affinity DataKi:  105nMAssay Description:The ability of some of the ligands to bind to the CB1/CB2 receptors with a tight/irreversible binding mode was determined by measuring reductions in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
Go to US Patent

TargetCannabinoid receptor 2(Human)
Individual

US Patent
LigandPNGBDBM614255(US11746113, Compound 10.5)
Affinity DataKi:  105nMAssay Description:The ability of some of the ligands to bind to the CB1/CB2 receptors with a tight/irreversible binding mode was determined by measuring reductions in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
Go to US Patent

TargetCannabinoid receptor 2(Human)
Individual

US Patent
LigandPNGBDBM614256(US11746113, Compound 10.6)
Affinity DataKi:  105nMAssay Description:The ability of some of the ligands to bind to the CB1/CB2 receptors with a tight/irreversible binding mode was determined by measuring reductions in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
Go to US Patent

TargetCannabinoid receptor 1(Human)
Individual

US Patent
LigandPNGBDBM614257(US11746113, Compound 10.7)
Affinity DataKi:  105nMAssay Description:The ability of some of the ligands to bind to the CB1/CB2 receptors with a tight/irreversible binding mode was determined by measuring reductions in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
Go to US Patent

TargetCannabinoid receptor 1(Human)
Individual

US Patent
LigandPNGBDBM614259(US11746113, Compound 10.9)
Affinity DataKi:  105nMAssay Description:The ability of some of the ligands to bind to the CB1/CB2 receptors with a tight/irreversible binding mode was determined by measuring reductions in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
Go to US Patent

TargetCannabinoid receptor 2(Human)
Individual

US Patent
LigandPNGBDBM614259(US11746113, Compound 10.9)
Affinity DataKi:  105nMAssay Description:The ability of some of the ligands to bind to the CB1/CB2 receptors with a tight/irreversible binding mode was determined by measuring reductions in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
Go to US Patent

TargetCannabinoid receptor 1(Human)
Individual

US Patent
LigandPNGBDBM614261(US11746113, Compound 10.11)
Affinity DataKi:  105nMAssay Description:The ability of some of the ligands to bind to the CB1/CB2 receptors with a tight/irreversible binding mode was determined by measuring reductions in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
Go to US Patent

Displayed 1 to 50 (of 86 total ) | Next | Last >>
Jump to: